453 related articles for article (PubMed ID: 23475304)
1. CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.
Ding G; Xu W; Liu H; Zhang M; Huang Q; Liao Z
Mol Biol Rep; 2013 May; 40(5):3483-91. PubMed ID: 23475304
[TBL] [Abstract][Full Text] [Related]
2. Association between cytochrome P450 1A1 MspI polymorphism and endometrial cancer risk: a meta-analysis.
Han L; Liu Y; Cao W; Yuan X; Li C
Tumour Biol; 2013 Oct; 34(5):2545-50. PubMed ID: 23918309
[TBL] [Abstract][Full Text] [Related]
3. Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Evidence from 2013 cases and 2903 controls.
Zhuo W; Zhang L; Qiu Z; Zhu B; Chen Z
Gene; 2012 Nov; 510(1):14-21. PubMed ID: 22964275
[TBL] [Abstract][Full Text] [Related]
4. Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population.
Zheng H; Zhao Y
Eur J Med Res; 2015 Mar; 20(1):46. PubMed ID: 25886559
[TBL] [Abstract][Full Text] [Related]
5. CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects.
Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
J Exp Clin Cancer Res; 2012 Jul; 31(1):62. PubMed ID: 22846179
[TBL] [Abstract][Full Text] [Related]
6. Impact of CYP1A1 Polymorphisms on Susceptibility to Chronic Obstructive Pulmonary Disease: A Meta-Analysis.
Wang CD; Chen N; Huang L; Wang JR; Chen ZY; Jiang YM; He YZ; Ji YL
Biomed Res Int; 2015; 2015():942958. PubMed ID: 26425562
[TBL] [Abstract][Full Text] [Related]
7. Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis.
Xia L; Gao J; Liu Y; Wu K
Tumour Biol; 2013 Feb; 34(1):223-30. PubMed ID: 23055196
[TBL] [Abstract][Full Text] [Related]
8. The effect of CYP1A1 and CYP1A2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis.
Xue H; Lu Y; Xue Z; Lin B; Chen J; Tang F; Huang G
Tumour Biol; 2014 May; 35(5):4741-56. PubMed ID: 24443269
[TBL] [Abstract][Full Text] [Related]
9. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.
Zhan P; Wang Q; Qian Q; Wei SZ; Yu LK
J Exp Clin Cancer Res; 2011 Oct; 30(1):99. PubMed ID: 22014025
[TBL] [Abstract][Full Text] [Related]
10. The cytochrome P4501A1 gene polymorphisms and endometriosis: a meta-analysis.
Fan W; Huang Z; Xiao Z; Li S; Ma Q
J Assist Reprod Genet; 2016 Oct; 33(10):1373-1383. PubMed ID: 27525656
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk.
Guo R; Guo X
Tumour Biol; 2012 Aug; 33(4):1125-32. PubMed ID: 22359202
[TBL] [Abstract][Full Text] [Related]
12. CYP1A1 MspI polymorphisms and lung cancer risk: an updated meta-analysis involving 20,209 subjects.
Ji YN; Wang Q; Lin XQ; Suo LJ
Cytokine; 2012 Aug; 59(2):324-34. PubMed ID: 22579698
[TBL] [Abstract][Full Text] [Related]
13. MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysis.
Wu B; Liu K; Huang H; Yuan J; Yuan W; Wang S; Chen T; Zhao H; Yin C
PLoS One; 2013; 8(12):e85166. PubMed ID: 24391993
[TBL] [Abstract][Full Text] [Related]
14. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.
Yao L; Yu X; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(2):503-7. PubMed ID: 20052535
[TBL] [Abstract][Full Text] [Related]
15. Quantitative synthesis of the association between the cytochrome P450 1A1 Ile462Val polymorphism and prostate cancer risk.
Han G; Ma Y; Liu P; Wei X; Zhang X; Zhu F
Tumour Biol; 2013 Jun; 34(3):1511-6. PubMed ID: 23381648
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese.
Liu C; Jiang Z; Deng QX; Zhao YN
Asian Pac J Cancer Prev; 2014; 15(11):4689-95. PubMed ID: 24969905
[TBL] [Abstract][Full Text] [Related]
17. Association of CYP1A1 MspI polymorphism with oral cancer risk in Asian populations: a meta-analysis.
Xu JL; Xia R; Sun L; Min X; Sun ZH; Liu C; Zhang H; Zhu YM
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323067
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and ovarian cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP; Choussein S; Vlahos NF
Mol Biol Rep; 2012 Nov; 39(11):9921-30. PubMed ID: 22733497
[TBL] [Abstract][Full Text] [Related]
19. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis.
Zheng Y; Wang JJ; Sun L; Li HL
Mol Biol Rep; 2012 Apr; 39(4):3533-40. PubMed ID: 21710246
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of CYP1A1 MspI and GSTM1 genetic polymorphisms on risk of lung cancer: an updated meta-analysis.
Li W; Song LQ; Tan J
Tumour Biol; 2014 Sep; 35(9):9281-90. PubMed ID: 24938875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
